<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04650438</url>
  </required_header>
  <id_info>
    <org_study_id>2018-01578</org_study_id>
    <nct_id>NCT04650438</nct_id>
  </id_info>
  <brief_title>Sleep and Creativity</brief_title>
  <official_title>Sleep and Creativity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Creativity is a complex neuro-psycho-philosophical phenomenon that is difficult to define.&#xD;
      Neurocognitive models of creativity suggest that creativity is associated with the activity&#xD;
      of a distributed, bilateral fronto-temporal and parietal network. Therefore, a modulation of&#xD;
      frontal activity is necessary to allow a certain degree of &quot;controlled disinhibition&quot;, which&#xD;
      seems to be necessary for creative thinking. In addition, a modulation of the lower parietal&#xD;
      lobe (IPL) might allow targeting the brain regions responsible for idea generation.&#xD;
&#xD;
      This project will investigate the application of transcranial magnetic stimulation (TMS) with&#xD;
      the intent of modulating creativity performance of healthy subjects. Resting state&#xD;
      electroencephalography (EEG) that will be acquired pre- and post-TMS and participants'&#xD;
      creative performance will be measured.&#xD;
&#xD;
      Perspectives include a better understanding of the differences between high- and&#xD;
      low-creativity groups, as measured by a creativity test battery, in their response to TMS.&#xD;
      Additional perspectives are whether there are differences in creativity performance depending&#xD;
      on the stimulation location.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2022</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Single-blind, randomized, cross-over trial</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in creativity performance prior- and post-TMS</measure>
    <time_frame>2.5 hours</time_frame>
    <description>Change in creativity performance (as expressed by a summary score of single tests from a creativity test battery) prior- and post-TMS in low- and high-creativity groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in creativity performance prior- and post-TMS depending on stimulation location</measure>
    <time_frame>2.5 hours</time_frame>
    <description>Change in creativity performance (as expressed by a summary score of single tests from a creativity test battery) prior- and post-TMS depending on the stimulation location (left IFG versus left IPL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Creativity Performance in Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>High-creativity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Here participants are allocated to the high-creativity group. Resting state EEG will be measured pre- and post-TMS and participants' creative performance will be measured by means of a creativity test battery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-creativity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Here participants are allocated to the low-creativity group. Resting state EEG will be measured pre- and post-TMS and participants' creative performance will be measured by means of a creativity test battery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS) over the left inferior frontal gyrus (IFG)</intervention_name>
    <description>MagPro X100, with MagPro software version 7.1; connected to a figure-of-eight coil (MC-B70) or a circular coil (MC-125). The device is CE marked and bears an ISO 13485 certificate complying with good manufacturing practice. Continuous theta burst stimulation protocol will be applied.</description>
    <arm_group_label>High-creativity</arm_group_label>
    <arm_group_label>Low-creativity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS) over the left inferior parietal lobule (IPL)</intervention_name>
    <description>MagPro X100, with MagPro software version 7.1; connected to a figure-of-eight coil (MC-B70) or a circular coil (MC-125). The device is CE marked and bears an ISO 13485 certificate complying with good manufacturing practice. Continuous theta burst stimulation protocol will be applied.</description>
    <arm_group_label>High-creativity</arm_group_label>
    <arm_group_label>Low-creativity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent as documented by signature&#xD;
&#xD;
          -  Age between 18 and 70 years&#xD;
&#xD;
          -  Neurologically healthy, i.e., with no documented or present neurological disease or&#xD;
             brain injury&#xD;
&#xD;
          -  Normal or corrected-to-normal visual acuity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any instable medical condition, in particular epilepsy (past or pre-sent, including&#xD;
             seizures or febrile convulsions)&#xD;
&#xD;
          -  Any surgical intervention to the brain&#xD;
&#xD;
          -  Implanted medical devices (e.g., cochlear implants, infusion pumps, neurostimulators,&#xD;
             pacemakers)&#xD;
&#xD;
          -  Presence of metal in the region of the head (excluding fixed dental implants such as&#xD;
             tooth fillings or fixed dental braces)&#xD;
&#xD;
          -  Drug or alcohol abuse&#xD;
&#xD;
          -  Intake of any medication that is likely to lower seizure threshold&#xD;
&#xD;
          -  For female participants: in order to participate in the study, female patients in&#xD;
             reproductive age need to take a pregnancy test (a stand-ard urine pregnancy test will&#xD;
             be provided).&#xD;
&#xD;
          -  Previous enrolment in a creativity study of the same PI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>René M. Müri, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudio Bassetti, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Neurology Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aleksandra Eberhard-Moscicka, Dr.</last_name>
    <phone>31 632 67 28</phone>
    <phone_ext>+41</phone_ext>
    <email>aleksandra.eberhard@neuro.unibe.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology Inselspital, Bern University Hospital</name>
      <address>
        <city>Berne</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>René M. Müri, Prof. Dr.</last_name>
      <email>rene.mueri@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Beaty RE, Benedek M, Wilkins RW, Jauk E, Fink A, Silvia PJ, Hodges DA, Koschutnig K, Neubauer AC. Creativity and the default network: A functional connectivity analysis of the creative brain at rest. Neuropsychologia. 2014 Nov;64:92-8. doi: 10.1016/j.neuropsychologia.2014.09.019. Epub 2014 Sep 20.</citation>
    <PMID>25245940</PMID>
  </reference>
  <reference>
    <citation>Jung J, Bungert A, Bowtell R, Jackson SR. Vertex Stimulation as a Control Site for Transcranial Magnetic Stimulation: A Concurrent TMS/fMRI Study. Brain Stimul. 2016 Jan-Feb;9(1):58-64. doi: 10.1016/j.brs.2015.09.008. Epub 2015 Sep 25.</citation>
    <PMID>26508284</PMID>
  </reference>
  <reference>
    <citation>Lustenberger C, Boyle MR, Foulser AA, Mellin JM, Fröhlich F. Functional role of frontal alpha oscillations in creativity. Cortex. 2015 Jun;67:74-82. doi: 10.1016/j.cortex.2015.03.012. Epub 2015 Apr 1.</citation>
    <PMID>25913062</PMID>
  </reference>
  <reference>
    <citation>Nyffeler T, Wurtz P, Pflugshaupt T, von Wartburg R, Luthi M, Hess CW, Muri RM. One-Hertz transcranial magnetic stimulation over the frontal eye field induces lasting inhibition of saccade triggering. Neuroreport. 2006 Feb 27;17(3):273-5.</citation>
    <PMID>16462596</PMID>
  </reference>
  <reference>
    <citation>Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14. Review.</citation>
    <PMID>19833552</PMID>
  </reference>
  <reference>
    <citation>Park HR, Kirk IJ, Waldie KE. Neural correlates of creative thinking and schizotypy. Neuropsychologia. 2015 Jul;73:94-107. doi: 10.1016/j.neuropsychologia.2015.05.007. Epub 2015 May 12.</citation>
    <PMID>25979607</PMID>
  </reference>
  <reference>
    <citation>Vartanian O, Beatty EL, Smith I, Blackler K, Lam Q, Forbes S. One-way traffic: The inferior frontal gyrus controls brain activation in the middle temporal gyrus and inferior parietal lobule during divergent thinking. Neuropsychologia. 2018 Sep;118(Pt A):68-78. doi: 10.1016/j.neuropsychologia.2018.02.024. Epub 2018 Feb 23.</citation>
    <PMID>29477840</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 19, 2020</study_first_submitted>
  <study_first_submitted_qc>November 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

